Dr. Giuseppe Banna, MD

Dr. Giuseppe Banna is a consultant medical oncologist whose practice focuses on lung cancer and urological malignancies, including prostate, bladder and renal cancers. He combines hands‑on clinical care at Portsmouth Hospitals with a substantial translational research portfolio developing predictive models and optimised systemic‑therapy strategies.

Clinical & Academic Focus

• Specialises in systemic anti‑cancer treatments for lung and uro‑oncology tumours, including chemotherapy, immunotherapy, targeted agents and hormonal therapies
• Experienced in managing complex metastatic disease and in integrating clinical‑trial options into routine care
• Advising on biomarker‑driven treatment selection and frailty‑adapted therapy

Research & Teaching

• Has led more than 20 clinical and translational studies as principal investigator across lung and urological cancers, working with academic and commercial partners
• Research interests include predictive models for immunotherapy using blood immune‑inflammatory indices, adherence to oral anticancer medicines, and tools for frailty assessment in oncology
• Author of around 250 peer‑reviewed publications and associate editor for several oncology journals

Leadership & Honours

• Referee for international funding bodies and reviewer for multiple oncology journals
• Active member of international societies including ESMO and SIOG, contributing to global discussions on geriatric oncology and immunotherapy

A Personal Note

Dr. Banna is recognised for his meticulous, data‑driven approach and his commitment to tailoring treatment intensity to each patient’s biology and fitness. He aims to combine cutting‑edge science with compassionate support so that people living with lung or urological cancers receive individualised care and feel fully involved in treatment decisions.